Podchaser Logo
Home
Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Released Monday, 25th March 2024
Good episode? Give it some love!
Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Bonus Episode: Anti-TNFs in IBD 8/10. The Impact of Switching to Biosimilars for Inflammatory Bowel Disease

Monday, 25th March 2024
Good episode? Give it some love!
Rate Episode

Expanding the discussion of the use of anti-TNF biosimilars, in this episode, our expert panel provides insights on switching and the handling of adalimumab biosimilars.

This podcast series has been supported by Viatris, who were not involved in the creation of this content.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features